Mundipharma: Mundipharma to acquire rezafungin assets from Cidara Therapeutics
Mundipharma is to acquire all assets and rights related to antifungal candidate Rezzayo (rezafungin) from Cidara Therapeutics.
Read full article »
Mundipharma is an England-based pharmaceutical company that accelerates the development of medicines for patients and healthcare providers.
Read more